Results for osmotic translation from English to Maltese

the solution is a clear, colourless to pale yellow and iso-osmotic solution.
is-soluzzjoni hija ċara, bla kulur sa isfar ċar u iso-osmotika.

these include acute renal failure, acute tubular necrosis, proximal tubular nephropathy and osmotic nephrosis.
dawn jinkludu insuffiċjenza akuta tal-kliewi, nekrosi tubulari akuta, nefropatija tubulari prossimali u nefrosi osmotika.

the effect of empagliflozin on urinary glucose excretion is associated with osmotic diuresis, which could affect the hydration status.
l-effett ta' empagliflozin fuq l-eliminazzjoni tal-glukosju bl-awrina huwa assoċjat ma' dijuresi osmotika, li jista' jaffettwa l-istat ta' idratazzjoni.

in the kidney, desoxycortone causes sodium and chloride ion retention, and hydrogen and potassium ion excretion, creating an osmotic gradient.
fil-kliewi, desoxycortone jikkawża żamma tal-joni tas-sodium u l-chloride, u tneħħija tal- joni tal-hydrogen u l-potassium, u b’hekk joħloq gradjent osmotiku.

the effect of empagliflozin on urinary glucose excretion is associated with osmotic diuresis, which could affect hydration status of patients age 75 years and older.
l-effett ta’ empagliflozin fuq l-eliminazzjoni tal-glukosju bl-awrina huwa assoċjat ma’ dijuresi osmotika, li tista’ taffettwa l-istat ta’ idratazzjoni ta’ pazjenti li għandhom 75 sena u ikbar.

compared with a constipation treatment working through osmotic action, prokinetic stimulation with prucalopride increased colonic motility as measured by the number of hapcs during the first 12 hours after intake of the investigational product.
meta mqabbla ma’ kura għal stitikezza li taħdem permezz ta’ azzjoni osmotika, stimulazzjoni prokinetika b’prucalopride żiedet il-motilità kolonika kif imkejla min-numru ta’ hapcs matul l- ewwel 12-il siegħa wara t-teħid tal-prodott taħt investigazzjoni.

the active substance in bronchitol, mannitol, is a naturally occurring polyol (a sugar alcohol) that is widely used as an osmotic agent.
is-sustanza attiva fi bronchitol, il-mannitol, hija polyol preżenti b’mod naturali (alkoħol zokkri) li tintuża b’mod komuni bħala aġent osmotiku.

the osmotic gradient promotes water absorption from the renal tubules resulting in increased extracellular fluid volume, leading to blood volume expansion, improved venous return to the heart, and increased cardiac output.
il-gradjent osmotiku jippromwovi assorbiment tal-ilma mit-tubuli renali u jwassal għal żieda fil-volum ta’ fluwidu ekstraċellulari, li jwassal għal żieda fil-volum tad-demm, titjib fir-ritorn tad-demm lejn il-qalb, u żieda fil-volum ta’ demm ippumpjat mill-qalb.

one pre-filled syringe contains 3.6 mg/90 microlitres (40 mg/ml) in iso-osmotic solution.
siringa mimlija għal-lest waħda fiha 3.6 mg/90 mikrolitru (40 mg/ml) f’soluzzjoni iso-osmotika.

concomitant use of samsca with other treatments for hyponatraemia or other medicinal products that increase serum sodium concentration may result in a higher risk for developing rapid correction of serum sodium (see section 4.4) and is therefore not recommended during initial treatment or for other patients with very low baseline serum sodium concentrations where rapid correction may represent a risk for osmotic demyelination (see section 4.4).
l-użu ta’ samsca flimkien ma’ kura oħra għal iponatrimija jew prodotti mediċinali oħra li jżidu l-konċentrazzjoni tas-sodium fis-serum jistgħu jirriżultaw f’riskju ogħla li tiżviluppa korrezzjoni rapida ta’ sodium fis-serum (ara sezzjoni 4.4), u għalhekk mhux rakkomandat waqt kura inizjali jew għal pazjenti oħrajn b’konċentrazzjonijiet ta’ sodium fis-serum fil-linja bażi baxxi ħafna fejn korrezzjoni rapida jista’ jkollha riskju ta’ demajlinazzjoni osmotika (ara sezzjoni 4.4).